VCEL

Vericel Corporation

Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$34.14

Market Cap

$1.73B

Beta

1.19

P/E

112.2

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+16.45%

EPS Growth (YoY)+65.66%

Revenue CAGR 3Y+18.90%

P/E Ratio112.2

PEG Ratio1.69

FCF Yield+2.02%

Debt / Equity0.28

Interest Coverage17.5x

No credit card required

Already have an account? Sign in to view the full analysis for VCEL.